Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2021 08:10 ET | Source: The Insight Partners

Generic Oncology Drugs Market Growth Sturdy at 6.3% CAGR to Outstrip $36,029.60 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com

Pune, India., June 16, 2021 (GLOBE NEWSWIRE) -- Generic Oncology Drugs Market: Key InsightsAccording to our new research study on “Generic Oncology Drugs Market to 2027 – Global Analysis and...
April 23, 2021 08:30 ET | Source: CMI

Saudi Arabia Pharmaceutical Drugs Market to Surpass US$ 16,663.1 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE, April 23, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Saudi Arabia pharmaceutical drugs market is estimated to be valued at US$ 10,191.4 million in 2020 and is...
April 01, 2021 12:15 ET | Source: Acumen Research and Consulting

Generic Drugs Market Value Predicted To Reach US$ 627.6 Billion By 2027: Acumen Research And Consulting

Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Generic Drugs Market – Global Industry Analysis, Market Size, Opportunities and...
January 08, 2020 13:36 ET | Source: Hausfeld

Celgene Rescinds Agreement to Compensate Cancer Patients Days Before Christmas

WASHINGTON, Jan. 08, 2020 (GLOBE NEWSWIRE) -- On December 23, 2019, Celgene backed out of a settlement in which it had agreed to pay $55 million to end payors (consumers, insurers, union health and...
March 11, 2019 06:45 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®

NORTHVALE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today that it has entered into a license, supply, and distribution...
February 11, 2019 17:34 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, February 12th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
February 07, 2019 06:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019

Northvale, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
December 11, 2018 07:30 ET | Source: SunGen Pharma LLC

SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA

PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
December 10, 2018 12:28 ET | Source: SunGen Pharma LLC

SunGen Pharma Receives US FDA Approval for Prednisone ANDA

PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
December 10, 2018 07:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®

NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...